| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.1 |